Literature DB >> 12166606

Postprandial hyperglycaemia: noxious effects on the vessel wall.

Markolf Hanefeld1.   

Abstract

In recent years postchallenge or postprandial hyperglycaemia has been found to be an independent risk factor for cardiovascular comorbidities and all-cause mortality in impaired glucose tolerance (IGT) and type 2 diabetes. With the database of the Risk Factors in IGT for Atherosclerosis and Diabetes (RIAD) study, it was also shown that atherosclerosis as measured by intima-media thickness of the common carotid arteries was associated with 2-hour postchallenge glucose level when HbA1c was normal. Taken together there are now comprehensive and consistent data from pathophysiological as well as epidemiological studies that excessive post-load glucose excursions have acute and chronic harmful effects on the endothelium and vessel wall. This is supported by four outcome studies that included control of postprandial glucose to prevent cardiovascular disease: Diabetes Intervention Study (DIS), Kumamoto study, DIGAMI study, and STOP-NIDDM trial. Therefore, in addition to HbA1c and fasting blood glucose, postprandial glucose monitoring should be an integral part of treatment to prevent acute and chronic complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12166606

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  6 in total

1.  Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.

Authors:  Boris P Kovatchev; John Crean; Anthony McCall
Journal:  Diabetes Technol Ther       Date:  2008-10       Impact factor: 6.118

2.  Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.

Authors:  Andreas Pfützner; Markolf Hanefeld; Lida A Dekordi; Jürgen Müller; Iris Kleine; Winfried Fuchs; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

3.  Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial.

Authors:  Marta Garaulet; Jesus Lopez-Minguez; Hassan S Dashti; Céline Vetter; Antonio Miguel Hernández-Martínez; Millán Pérez-Ayala; Juan Carlos Baraza; Wei Wang; Jose C Florez; Frank A J L Scheer; Richa Saxena
Journal:  Diabetes Care       Date:  2022-03-01       Impact factor: 19.112

4.  Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study.

Authors:  Dan Lundblad; Mats Eliasson
Journal:  Cardiovasc Diabetol       Date:  2003-08-21       Impact factor: 9.951

5.  Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.

Authors:  Mei-Yueh Lee; Pi-Jung Hsiao; Yu-Ting Huang; Jiun-Chi Huang; Wei-Hao Hsu; Szu-Chia Chen; Shyi-Jang Shin
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

6.  Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.

Authors:  Ya-Fei Yang; Tsai-Chung Li; Chia-Ing Li; Chiu-Shong Liu; Wen-Yuan Lin; Sing-Yu Yang; Jen-Huai Chiang; Chiu-Ching Huang; Fung-Chang Sung; Cheng-Chieh Lin
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.